ASP Isotopes vs Flexible Solutions International
ASPI and FSI side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASPI and FSI compare
ASP Isotopes is the larger company, worth 3.4 times as much as Flexible Solutions International ($267M against $79.6M).
ASP Isotopes grew revenue faster over the last twelve months (573% versus −4.7% for Flexible Solutions International).
Flexible Solutions International keeps more of each dollar of sales as profit, with a net margin of −8.8% compared with −380% at ASP Isotopes.
ASP Isotopes scores higher on the StockData Score (6 against 5 for Flexible Solutions International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASPI | FSI |
|---|---|---|
| Size and price | ||
| Market cap | $267M | $79.6M |
| Share price | $1.74 | $6.23 |
| Change, 1 year | −80.4% | −22.4% |
| Change, 5 years | – | 66.1% |
| Beta (5Y) | 1.94 | 1.02 |
| Employees | 271 | 78 |
| StockData Score | ||
| Total score | 6 (better) | 5 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 0 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 8.6× | 2.2× (better) |
| P/B | 1.0× (better) | 2.1× |
| EV/EBITDA | – | 69.9× |
| FCF yield | −31.3% | −4.4% (better) |
| Fair value | $5.25 | $2.26 |
| Margin of safety | 66.9% (better) | −175% |
| Growth | ||
| Revenue growth (TTM) | 573% (better) | −4.7% |
| Revenue growth, 5Y average | – | 4.2% |
| Net income growth (TTM) | – | −202% |
| EPS growth (TTM) | – | −204% |
| EPS growth, 5Y average | – | −24.2% |
| Profitability | ||
| Gross margin | 18.3% | 19.1% (better) |
| Operating margin | −321% | −2.6% (better) |
| Net margin | −380% | −8.8% (better) |
| FCF margin | −271% | −9.8% (better) |
| Return on equity | −80.9% | −8.2% (better) |
| Return on invested capital | −549% | −2.1% (better) |
| Financial health | ||
| Debt / equity | 0.23 | 0.11 (better) |
| Net debt / EBITDA | – | −2.99 |
| Interest coverage | −25.3× | – |
| Current ratio | 3.87 (better) | 2.82 |
| Altman Z-score | −0.22 | 3.98 (better) |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Buyback yield | – | −0.33% |
| Shareholder yield | 0.00% (better) | −0.33% |
| Ownership | ||
| Held by institutions | 42.7% | 9.1% |
| Held by insiders | 10.7% | 36.1% |
| Insider net buying, 12 months | −$7.7M | −$789K (better) |
| Short interest, % of float | 22.9% | 1.1% |
Go deeper
- ASPI stock overview
- ASPI income statement
- ASPI valuation and score
- FSI stock overview
- FSI income statement
- FSI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.